ASMLs, Supply

ASML's Supply Squeeze Meets a Market That Won't Pay Any Price for AI

Published on 10/23/2026 at 15:31 | Editorial boerse-global.de
ASML's 6.5% drop reflects AI financing worries, not demand. Q3 revenue hit EUR 11.7B, and 2027-28 capacity may fall short of customer demand.
ASML NL0010273215 Architekturfoto zeigt modernes Halbleiter Fertigungsgebäude bei goldenem Abendlicht symmetrisch aufgenommen Illustration mit AI erstellt.

A 6.5% slide in ASML shares has little to do with the order book and everything to do with who is footing the bill for the AI buildout — a distinction worth keeping straight as headlines blur three separate stories.

The Dutch lithography giant's stock came under pressure yesterday as a global technology selloff swept through markets, with Reuters pointing to renewed anxiety over AI spending weighing on US equities. That is a financing question, not a demand question. ASML's own guidance says its planned delivery capacity for 2027 and 2028 will fall short of what customers want to buy.

The company said on October 14 that it is weighing capacity additions beyond its previously communicated plan — with the extra expansion eyed for 2028. Nothing has been decided, and no board approval has been announced. Reuters picked up the supply gap on October 15, pairing it with a reminder that order intake remains strong. Winning more business was never the problem; serving the business already booked is.

A quarter that undercuts the panic narrative

Hard numbers back that up. ASML reported third-quarter 2026 net revenue of EUR 11.7 billion and net profit of EUR 5.0 billion. For the fourth quarter, management guided to net revenue of EUR 14.2–15.2 billion — a forecast, not booked revenue, but hardly the profile of a company watching demand evaporate.

Which is why the selloff should not be read as the market pricing in a demand collapse the company has actually reported. Full order books, however, offer no protection against doubts about longer-term expectations — and those doubts are what drove the tape.

Should investors sell immediately? Or is it worth buying ASML Holding?

JPMorgan's Sandeep Deshpande captured the tension neatly on October 15, trimming his price target to $2,350 from $2,400 while keeping an overweight rating. Lower target, same conviction: a template for how the Street is treating the pullback.

Musk's Terafab remark is a customer's claim, not an ASML order

Into this mix came Elon Musk. The Tesla and SpaceX chief said on Tuesday that ASML and other equipment suppliers had accelerated deliveries for the Terafab chip project. Media reports suggest Terafab expects its first ASML EUV lithography system by mid-2027, with volume production targeted for the third or fourth quarter of 2028 — a timeline Musk himself called extremely ambitious.

Worth being precise here: that was Musk speaking about his suppliers, not ASML confirming an order. Such project chatter rounds out the demand picture but cannot substitute for a company-issued order confirmation. For anyone valuing ASML, the line between customer ambition, delivery reports and corporate disclosure is the one that matters.

Besi draws a line under the hybrid bonding rumor

A separate thread got clearer treatment this week. BE Semiconductor Industries does not see ASML as a hybrid bonding competitor, according to chief executive Richard Blickman, who spoke to Reuters yesterday. The two Dutch companies are, he said, working together to improve precision in chip placement.

That framing puts collaboration front and center. ASML, for its part, has not confirmed a Reuters report about a rival tool under development. The gap between an unconfirmed report and a confirmed product expansion is exactly where investors can get lost — and Blickman's comments describe cooperation, not a looming head-to-head fight. No new revenue line for ASML follows from them, nor does the thesis of an imminent competitive clash.

Three stories, one discipline

Strip it back and the week offered three distinct items: a sentiment-driven share price drop tied to AI funding worries, a supply constraint that management has acknowledged and is studying how to ease, and a clarification on the competitive landscape that leans toward partnership. Only the middle one touches ASML's operating reality, and it points to scarcity rather than slack. The rest is noise that rewards a careful reading — and punishes those who treat a customer's ambition or an unconfirmed report as a company statement.

Ad

ASML Holding Stock: New Analysis - 23 October

Fresh ASML Holding information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated ASML Holding analysis...

Disclaimer...
en | NL0010273215 | ASMLS | boerse | 70399306 |